Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

New emulsion formulation of tacrolimus provides local immunosuppression

July 30, 1997

SangStat Medical reports encouraging phase III results with Thymoglobulin

July 29, 1997

DynaGen expands ImmuDyn development

July 24, 1997

Mycophenolic acid derivatives with immunosuppressive activity claimed

July 17, 1997

Intranasal flu vaccine effective and safe in children

July 16, 1997

Vical and Pasteur Merieux Connaught initiate phase I malaria trial

July 14, 1997

Virus Research Institute's rotavirus vaccine enters phase II

July 11, 1997

Lepetit discovers IL-1RI inhibitors from microbial samples

July 10, 1997

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Preliminary results reported for Cortecs' Flustat

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...